Adjuvant vs. salvage radiotherapy for pathologically advanced prostate cancer
Authors:
- 1 May 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Urology
- Vol. 20 (3) , 229-233
Abstract
This article considers the efficacy and toxicity of postoperative radiotherapy to the prostate bed after radical prostatectomy. It has a particular focus on the debate concerning the optimum timing of postoperative radiotherapy: adjuvant treatment for all high-risk cases vs. salvage treatment at the time of prostate-specific antigen relapse. Postoperative radiotherapy has been shown, in a mature randomized trial, to improve overall survival after radical prostatectomy. Randomized trials have also provided good data on the morbidity of postoperative radiotherapy. Postoperative radiotherapy improves survival in patients with high-risk pathological features at radical prostatectomy at the cost of moderate urinary and bowel toxicity. The optimum timing of postoperative radiotherapy, and in particular the relative merits of adjuvant vs. salvage radiotherapy, remains uncertain.Keywords
This publication has 22 references indexed in Scilit:
- Adjuvant therapy after radical prostatectomy: Clinical considerationsSurgical Oncology, 2009
- Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical TrialJournal of Urology, 2009
- Prostate Cancer–Specific Survival Following Salvage Radiotherapy vs Observation in Men With Biochemical Recurrence After Radical ProstatectomyJAMA, 2008
- Resolving the Optimal Timing of Radiotherapy After Radical Prostatectomy: The Need for Further ResearchJournal of Clinical Oncology, 2008
- Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical ProstatectomyJournal of Clinical Oncology, 2007
- Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): A new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomyBJU International, 2007
- Prognostic impact of positive surgical margins in surgically treated prostate cancer: Multi-institutional assessment of 5831 patientsUrology, 2005
- Biochemical (Prostate Specific Antigen) Recurrence Probability Following Radical Prostatectomy for Clinically Localized Prostate CancerJournal of Urology, 2003
- Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal CancerNew England Journal of Medicine, 2001
- Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant ChemotherapyNew England Journal of Medicine, 1997